Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Emtricitabine-containing HAART regimen is highly efficacious in French study

Feb. 3, 2000

NDA filed for once-daily didanosine capsules

Feb. 2, 2000

1F7 antibody inhibits destruction of CD4+ cells

Feb. 2, 2000

Merck reports success with early study of HIV-1 integrase inhibitors

Feb. 1, 2000

Trimeris and Roche advance HIV fusion inhibitors in clinical testing

Feb. 1, 2000

ML Laboratories updates AIDS products

Jan. 31, 2000

Boehringer Ingelheim adds structurally novel HIV protease inhibitor to R&D portfolio

Jan. 31, 2000

Avant and WRAIR to collaborate on HIV vaccine development

Jan. 28, 2000

New study will evaluate Remune plus HAART in early-stage HIV

Jan. 27, 2000

Combination efavirenz, nelfinavir and NRTIs assessed in children with HIV-1

Jan. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...